Clinical trials: Radiodermatitis
Radiation Dermatitis
KeraStat(R) Cream for Radiation Dermatitis
The primary objectives of the proposed research are to evaluate patient use of KeraStat Cream and collect data to inform a larger future trial.
- Trial name
- NCT03559218
- Testing
- KeraStat(R) Cream, Standard of care
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- KeraNetics, LLC
Breast Cancer, Radiation Dermatitis
The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients
Radiation dermatitis (RD) is one of the most common side effects of Radiation therapy (RT) and 95% of patients receiving RT may experience some form of radiation dermatitis.
- Trial name
- NCT04481802
- Testing
- RadiaAce gel, Biafine
- Where
- Israel
- Volunteers
- 120 people
- Sponsor
- AceTech
Radiation Dermatitis
Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
The purpose of this study is to characterize the skin microbiome profile of breast cancer patients before and after receiving Radio Therapy treatments, and evaluate the relationship between the microbiome profile and radiation…
- Trial name
- NCT04268056
- Testing
- Collection of skin culture samples
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- AceTech
Radiation Dermatitis, Breast Cancer
Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Breast Radiotherapy
This study evaluated a mushroom extract-containing topical cosmetic formulation for skin care in women receiving radiotherapy to the breast after breast-conserving surgery.
- Trial name
- NCT07755553
- Testing
- Mushroom extract-containing topical cosmetic formulation, Usual moisturizing cosmetic care
- Where
- Spain
- Volunteers
- 50 people
- Sponsor
- Hifas da Terra S.L.
Breast Cancer
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Radiation dermatitis is experienced by almost all patients (up to 95%) receiving radiation therapy for cancer. Radiation dermatitis can be a serious condition because, in addition to its direct physical complications and the…
- Trial name
- NCT02142959
- Testing
- Omaveloxolone Lotion 0.5%, Omaveloxolone Lotion 3%, Vehicle Lotion
- Where
- 27 sites in United States
- Volunteers
- 187 people
- Sponsor
- Biogen